Treatment Duration for UTIs in Males with Paraplegia

Classification and Risk Factors

• UTIs in males with paraplegia are considered complicated UTIs due to both male gender and neurogenic bladder dysfunction 1, 2
• Common risk factors in this population include incomplete bladder emptying 1
• Catheterization (indwelling or intermittent) is a risk factor for UTIs in males with paraplegia 2
• Vesicoureteral reflux is a risk factor for UTIs in this population 1

Treatment Duration Guidelines

• A 14-day treatment course is recommended for males with paraplegia when prostatitis cannot be excluded 1, 2
• A 7-day treatment may be considered for males with paraplegia who have been afebrile for at least 48 hours and are hemodynamically stable 1, 2

Antibiotic Selection

• Empiric therapy should consider local resistance patterns and be adjusted based on culture results 1, 2
• Recommended empiric options include amoxicillin plus an aminoglycoside 3
• Fluoroquinolones (e.g., ciprofloxacin) should only be used when local resistance rates are <10% and treatment can be given entirely orally 1, 2
• Fluoroquinolones may be considered for patients with anaphylaxis to β-lactam antibiotics 3

Management of Underlying Factors

• Addressing any urological abnormalities and underlying complicating factors is important for managing UTIs in males with paraplegia 1, 2

Common Pitfalls to Avoid

• Using fluoroquinolones empirically when local resistance rates are high should be avoided 1, 2
• Failing to adjust therapy based on culture results should be avoided 1, 2
• Not addressing underlying urological abnormalities should be avoided 1, 2
• Unnecessarily prolonged treatment increases the risk of adverse effects and antimicrobial resistance 3, 4

Antibiotic Duration for Complicated UTI

Standard Treatment Duration for Complicated UTI

• The Clinical Microbiology and Infection guidelines recommend a minimum treatment duration of 7 days for most complicated UTIs in patients who are hemodynamically stable and afebrile for at least 48 hours 5
• The Clinical Microbiology and Infection guidelines confirm that short-duration therapy (5-7 days) results in similar clinical success as long-duration therapy (10-14 days) for complicated UTI, even in patients with bacteremia 5

Evidence Quality and Nuances

• Eight RCTs including >1,300 patients confirmed that 5-7 days results in similar clinical success as 10-14 days for complicated UTI 5

Common Pitfalls to Avoid

• The American Urological Association recommends against using 3-day courses for complicated UTI, as this duration is only appropriate for uncomplicated cystitis in women 6
• The Clinical Microbiology and Infection guidelines recommend against assuming all complicated UTIs require 14 days, as many can be effectively treated with 7 days if clinical criteria are met 5